Gene: P2RX2
Official Full Name: purinergic receptor P2X 2provided by HGNC
Gene Summary: The product of this gene belongs to the family of purinoceptors for ATP. This receptor functions as a ligand-gated ion channel. Binding to ATP mediates synaptic transmission between neurons and from neurons to smooth muscle. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Aug 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08099 | P2RX2 Knockout cell line (HEK293) | Human | P2RX2 | 1:3~1:6 | Negative | Online Inquiry |
P2RX2 Gene Knockout Cell Lines are genetically engineered cellular models that have been specifically designed to lack the expression of the P2X purinergic receptor 2 (P2RX2). This receptor plays a critical role in various physiological processes, including neurotransmission and the modulation of inflammatory responses. By creating cell lines that are deficient in P2RX2, researchers can rigorously investigate the biological impacts of this receptor's absence, allowing for novel insights into its involvement in pain pathways, neurodevelopmental disorders, and immune responses.
The key function of these knockout cell lines lies in their ability to facilitate detailed studies on the downstream signaling cascades influenced by P2RX2. The absence of the receptor allows researchers to explore how its signaling may contribute to various cellular responses, including changes in intracellular calcium levels, activation of mitogen-activated protein kinase (MAPK) pathways, and the release of pro-inflammatory cytokines. The knockout models serve as essential tools to dissect the receptor's role in both in vitro and in vivo studies, accelerating discoveries in pharmacology and toxicology.
The scientific importance of P2RX2 Gene Knockout Cell Lines is underscored by their potential applications in drug discovery and development. Targeting purinergic signaling has gained traction as a therapeutic strategy for conditions such as neuropathic pain, psychiatric disorders, and chronic inflammation. These cell lines offer a reliable platform for screening new compounds that could modulate P2RX2 activity and thus inform the design of targeted therapies.
Compared to alternatives such as pharmacological inhibitors or wild-type controls, P2RX2 Gene Knockout Cell Lines provide a more precise and reproducible model for understanding receptor function. They enable researchers to bypass the complexities associated with off-target effects and emphasize the direct consequences of receptor absence. This specificity makes the knockout lines invaluable in generating robust, high-quality data that can lead to groundbreaking findings.
For researchers and clinicians, the availability of P2RX2 Gene Knockout Cell Lines represents an unprecedented opportunity to elucidate receptor-driven mechanisms with a level of accuracy previously unattainable. Utilizing these cell models can streamline research efforts, reduce experimental variability, and enhance the translation of preclinical findings into clinical applications.
Our company specializes in producing high-quality genetic tools and cell lines, leveraging our deep expertise in genetic engineering and cell biology. With our commitment to advancing research and therapeutic discovery, we provide researchers with the biological products they need to push the boundaries of scientific understanding.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.